Pain in the postoperative period following thoracotomy is frequently associated with clinical impairment of ventilatory mechanics, leading to atelectasis and pneumonia. Thoracic epidural analgesia using a mixture of local anaesthetic and opioid has been the gold standard for pain relief in many centres, but continuous paravertebral intercostal block using similar drugs has been proposed as a safe and simple alternative 1,2 .
SuMMARy
We prospectively evaluated the effect of clonidine as an adjuvant to bupivacaine for continuous paravertebral intercostal nerve block, measuring pain and sedation scores and pulmonary function tests. Thirty patients scheduled to undergo thoracotomy were randomized to receive either a bolus of 0.125% bupivacaine 2 mg/kg (group BUP) or 0.125% bupivacaine 2 mg/kg with clonidine 2 µg/kg (group BUP+CLO), followed by an infusion of 0.125% bupivacaine at 0.5 mg/kg/h, or 0.125% bupivacaine at 0.5 mg/kg/h with clonidine at 2 µg/kg/h, in respective groups, through a paravertebral intercostal catheter. Haemodynamic parameters, pain and sedation scores and pulmonary function tests were recorded at 6, 12, 24 and 48 hours after arrival in postoperative care unit.
There were significantly lower pain scores at rest and on coughing in group BUP+CLO compared with group BUP (P<0.01). Multiple comparisons revealed a significant reduction in pain score at each time point (P<0.01), except at 12h to 24h, in group BUP+CLO. Sedation scores were significantly higher in group BUP+CLO compared with group BUP at each time point (all P<0.01). There was a linear effect of time on sedation score in group BUP whereas in group BUP+CLO, the effect was quadratic. Patients in the clonidine group had a higher incidence of hypotension (P<0.01). There was no significant difference in pulmonary function between the groups.
We conclude that using clonidine as an adjunct to bupivacaine for continuous paravertebral intercostal nerve block improves pain relief after thoracotomy, but hypotension and sedation are adverse effects interfering with its clinical application.
METhoDS
After approval by our institutional ethics committee, thirty patients undergoing posterolateral thoracotomy for carcinoma of the oesophagus were recruited for this prospective, randomized, double-blind study. Informed consent was obtained from each patient. Exclusion criteria were patient refusal, allergy to local anaesthetic, psychiatric disease, documented neurological or cardiopulmonary disorder, marked obesity and inability to comprehend pain scoring or the use of the hand-held spirometer.
on the day before surgery, use of the hand-held spirometer (Microlab Spiro) was explained to the patients and the best of three successive readings of forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1) and peak expiratory flow rate (PEFR) were recorded as preoperative baseline readings. Patients were also given instructions about filling out a linear visual analogue scale (VAS), graduated from 0 (no pain) to 10 (worst pain imaginable). Patients were randomized using a computer-generated random number table into two equal groups of fifteen: group BUP (bupivacaine only) and group BuP+Clo (bupivacaine with clonidine).
All patients were premedicated with diazepam 10 mg orally on the night before surgery and two hours prior to surgery and with glycopyrrolate 0.2 mg intramuscularly approximately one hour before surgery. At induction all patients received fentanyl 2 µg/kg. Anaesthesia was induced with thiopentone sodium 3-5 mg/kg and vecuronium bromide was used to aid endotracheal intubation with an appropriate sized double-lumen endobronchial tube. Anaesthesia was maintained with nitrous oxide and isoflurane in oxygen, and fentanyl and vecuronium as required. Monitoring included electrocardiogram (ECg), oxygen saturation (Spo 2 ), invasive blood pressure, ventilatory parameters, inspired oxygen fraction (Fio 2 ) and end-tidal gas concentrations.
The paravertebral catheter was placed according to the method described by Sabanathan and colleagues 2 . Toward the end of the operation and with the thorax still open, the parietal pleura was peeled back medially as far as the neck of the ribs to expose the intercostal nerves, starting at the thoracotomy opening and extending laterally for two intercostal spaces above and two below, avoiding perforation of the parietal pleura. A 16-gauge Tuohy needle was inserted percutaneously at a site about 3 cm medial to the posterior end of the wound to emerge at the angle of the rib of the thoracotomy incision. The needle was advanced until the tip of needle was within the chest cavity. There, after removing the needle, the tip of the catheter was inserted cranially for a distance of 3 to 4 cm into the paravertebral space, by making a small defect in the exposed ribs. The parietal pleura was reattached to the posterior edge of the wound, and the catheter, with a bacterial filter, was secured.
At the time of subcutaneous suturing of the thoracotomy wound, patients in group BuP received a bolus of 0.125% bupivacaine in a dose of 2 mg/kg, while patients in group BuP+Clo received 0.125% bupivacaine in a dose of 2 mg/kg, with clonidine 2 µg/kg.
At the end of the procedure all patients were extubated and taken to the postoperative recovery room to receive oxygen 4-6 l/min by facemask, continued for one day. In the recovery room, patients in group BuP were started on an infusion of 0.125% bupivacaine at 0.5 mg/kg/h. In group BuP+Clo, patients were started on an infusion of 0.125% bupivacaine (0.5 mg/kg/h) plus clonidine at 2 µg/kg/h. Intravenous morphine (3 mg) was given for rescue analgesia on request. An independent investigator, who was blinded to the drugs used, interviewed the patients every two hours for the first eight hours and every four hours subsequently. Patients were asked to assess the intensity of their rest pain and pain on coughing. Pulmonary function tests were recorded at 12, 24 and 48 hours postoperatively. Physiological parameters such as heart rate, blood pressure, Spo 2 and respiratory rate were monitored continuously by a Datex S/5 monitor. haemodynamics, side-effects and the use of additional analgesics were recorded. Hypotension, defined as systolic blood pressure <90 mmhg, was treated with mephentermine 3 mg intravenously, repeated as required. A six-point sedation score of 0 to 5 (0=alert, tense; 1=sedated, but not sleepy, with eyes open; 2=eyes closed almost continuously, responding immediately when spoken to; 3=eyes closed, responding to touch, but not when spoken to; 4=wakes up only after repeated tactile or acoustic stimuli; 5=difficult to rouse) was used to assess sedation.
All the exploratory analyses were performed for each of the variables. The Student's t-test and Mann-Whitney u-test was used to compare the continuous variables and the chi-square test was used to compare the categorical variables. The mean VAS pain score at rest, with coughing and the sedation score were compared between the groups as well as over time by using repeated measure ANoVA followed by multiple comparisons with Bonferroni's correction. P values <0.05 were considered statistically significant.
The minimum sample size was evaluated based on existing literature 5, 6 . The sample size required to detect a mean difference between groups of 40 using VAS pain score as the primary outcome, assuming a standard deviation of 0.54 and using a two-tailed t-test of the difference between the mean (5% level of significance and 80% power), was calculated to be 15 per group.
RESulTS
of thirty enrolled patients, two patients, one from each group, were excluded from the study. Both patients had haemodynamic compromise postoperatively and drug administration through the catheter as a continuous infusion was not started. There were no significant differences between the groups in age, weight, gender or duration of surgery ( Table 1) .
The estimated marginal mean of all VAS score means at rest in group BUP (2.05±0.13) was significantly higher than that of group BuP+Clo (1.33± 0.13, P=0.001). The pain scores at rest in the BUP+CLO group were significantly less at time points 6h, 12h and 24h (all P<0.01), with no difference between 24 and 48h. There was a linear effect of time on VAS scores at rest in each group and a significant interaction effect (time and group) on VAS score at rest, showing that this effect differed between groups over time (Figure 1) .
The overall estimated marginal mean of VAS scores with coughing in group BuP (3.82±0.12) was significantly higher than that of group BUP+CLO (2.91±0.12, P=0.001). Pain scores with coughing were significantly lower in group BUP+CLO compared with group BuP at all time points (P<0.01). There was a linear effect of time on these scores in both groups but no interaction effect (P=0.06) ( Figure 2 ). In group BUP+CLO there was a significant reduction in pain score over time (P<0.01) except at 12 and 24h, whereas in group BUP a significant change occurred at each time point, although the change between 12 and 24h was of borderline significance (P=0.049).
The overall estimated marginal mean of sedation scores was significantly lower in group BUP (1.27±0.08) compared with group BuP+Clo (2.41±0.08, P=0.001). Sedation scores were significantly higher among group BuP+Clo compared with group BuP at each time point (all P<0.01).
There was a linear effect of time on sedation score in group BuP, with scores decreasing over time, significantly so between time points 6 to 24h Values are mean±SD. (P<0.01) and 48h (P<0.01). The interaction effect (time and groups) was significant and in group BuP+Clo the time effect was quadratic. Sedation scores increased up to 24h, after which they decreased, with significant changes between 12 and 48h (P<0.01) and between 24 and 48h (P<0.01) ( Figure 3 ).
Significant deterioration was found in all three parameters of pulmonary function postoperatively, when compared to baseline, in both the groups, but there were no significant differences between the groups at any time ( Table 2) .
The average intraoperative fentanyl requirement was 162.5±25 µg in group BuP and 152.9±55.3 µg 
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Clonidine with Paravertebral buPivaCaine in group BuP+Clo. Two patients in group BuP+ CLO requested analgesia on the first postoperative day and this was achieved with intravenous morphine 6 mg. Among group BuP, three patients requested analgesia on the first postoperative day and they required intravenous morphine 15 mg, 9 mg and 6 mg respectively.
hypotension (systolic blood pressure <90 mmhg) was found in 11 of 14 patients in group BuP+Clo and three required colloid infusion plus intravenous mephentermine 3 mg to maintain a stable blood pressure. In comparison, no hypotension was found in any patient of group BuP (P<0.001). heart rate, respiratory rate and Spo 2 did not differ between groups and there were no other adverse effects noted in the postoperative period.
DISCuSSIoN
We found that continuous paravertebral intercostal nerve block with bupivacaine and clonidine provided significantly better pain relief at rest and on coughing when compared with bupivacaine alone. This was, however, achieved at the cost of a significantly higher incidence of hypotension and increased sedation, factors that might offset clinically the advantage of better analgesia.
The advantage of local anaesthetics used paravertebrally is segmental analgesia, without the side-effects of epidural administration such as sympathetic blockade, hypotension, muscle weakness and urinary retention. Several previous studies have used bupivacaine in concentrations from 0.25 to 0.5% 1, [7] [8] [9] [10] . however, in a pilot study we conducted, we found that our patients had significant hypotension with such concentrations and that adequate analgesia, with maintenance of cardiovascular stability, was better achieved with 0.125% bupivacaine. This was confirmed in our study, in which only three patients from group BuP requested additional analgesia. Because we used low doses of local anaesthetic we did not anticipate systemic toxicity and chose not to measure the serum bupivacaine concentrations.
Clonidine has been used as an adjunct to opioids and local anaesthetics to prolong duration and improve analgesic efficacy. Tschernko added 2 µg/kg of clonidine to bupivacaine for paravertebral intercostal nerve block and found that this afforded better and more prolonged pain relief than plain bupivacaine, as measured by VAS scores, additional analgesic requirements and improved arterial oxygenation 11 . They opined that the analgesic effect of clonidine was due to its action on α 2 -adrenergic receptors present on peripheral nerves, rather than a systemic effect of absorbed clonidine. Singelyn and colleagues also found a prolonged duration of analgesia when clonidine was used with mepivacaine for axillary brachial plexus block 12, 13 .
Clonidine, when used epidurally or systemically, produces centrally mediated hypotension at low to moderate doses. Systemic vasoconstriction produced by larger doses reverses the hypotensive effect 14, 15 . In doses greater than 100 µg, sedation and lowering of blood pressure and heart rate are seen. Transient oxyhaemoglobin desaturation was noted in several patients during deep sedation after administration of 300 µg clonidine 15 . At the dose used in our study, most patients had hypotension requiring intervention, although none needed the infusion stopped. Systemically absorbed clonidine may have contributed to this and it offsets one of the main advantages of paravertebral intercostal nerve block compared with thoracic epidural analgesia, namely a lower incidence of hypotension. It remains to be seen whether changing the dose of clonidine or decreasing the concentration of bupivacaine might result in better haemodynamic stability.
Thoracotomy has a detrimental effect on pulmonary mechanics, with one of the main causes considered to be the respiratory effects of severe pain 16 . Adequate pain relief allows patients to breathe deeply and cough effectively. We found that patients in group BUP+CLO had better pain scores but no significant improvement in pulmonary function. The FVC, FEV1 and PEFR decreased to about 40% of the preoperative value in both groups by 12 hours postoperatively and improved to about 60% of the preoperative value by 48 hours postoperatively. This is in accordance with a study by Bimston and co-workers who found no difference in pulmonary function testing in their epidural group, despite better pain scores 17 . Debreceni and colleagues also evaluated respiratory function and VAS scores in patients undergoing thoracotomy, including either thoracic epidural analgesia or continuous intercostal nerve block 7 . They found no significant difference in pulmonary function despite lower VAS scores in the epidural group. This may be because factors apart from pain, such as nerve, muscle and rib injury, contribute to respiratory function decay postoperatively. There was, however, no morbidity in any patient of any group.
In conclusion, clonidine, when used as an adjunct to bupivacaine for continuous intercostal block using a paravertebral catheter, improves analgesic efficacy after thoracotomy. hypotension occurred more frequently among patients receiving clonidine, but this responded well to treatment. Sedation was the major adverse effect of clonidine that interferes with its clinical application.
